Cart summary

You have no items in your shopping cart.

BAY 1135626

SKU: orb2564848

Description

BAY 1135626 synthesizes BAY 1129980, an Auristatin-based anti-C4.4A (LYPD3) antibody–drug conjugate (ADC) used in non–small cell lung cancer (NSCLC) research and anti-tumor studies.

Images & Validation

Key Properties

CAS Number1404071-37-9
MW1063.33
FormulaC55H86N10O11
SMILESC([C@H](NC([C@@H]([C@@H](OC)[C@]1(N(C(C[C@H]([C@@H](N(C([C@@H](NC([C@@H](N(CCCC(NNC(CCCCCN2C(=O)C=CC2=O)=O)=O)C)[C@H](C)C)=O)C(C)C)=O)C)[C@H](CC)C)OC)=O)CCC1)[H])C)=O)C(N)=O)C=3C=4C(NC3)=CC=CC4
TargetDrug-Linker Conjugates for ADC

Storage & Handling

Storage-20°C
DisclaimerFor research use only

Similar Products

Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

BAY 1135626 (orb2564848)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%